This scrutiny centers on the potential applications of bacteriophages in both healthcare and agriculture, recognizing the regulatory challenges that hinder their prompt deployment.
Steven Theriault is convinced he has the solution to an urgent global public health threat antibiotic resistance. But he can’t get his bacteria-killing viruses approved through what he calls Canada’s rigid and outdated regulatory system.